Improving preclinical models of HIV microbicide efficacy

Trends in Microbiology

Volumn 23, Issue 8, 2015, Pages 445-447

  Roan, Nadia R ^a,b   Münch, Jan ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GLADSTONE INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (United States)

^c UNIVERSITY HOSPITAL ULM   (Germany)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; MARAVIROC; MICROBICIDE; ANTIINFECTIVE AGENT;

CD4+ T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; NOTE; PRIORITY JOURNAL; SEMINAL PLASMA; SEXUAL TRANSMISSION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; UTERINE CERVIX MUCUS; VAGINA FLORA; VAGINA MUCOSA; VIRUS ATTACHMENT; VIRUS INFECTIVITY; VIRUS TRANSMISSION; ANIMAL; DISEASE MODEL; DISEASE TRANSMISSION; HIV INFECTIONS; ISOLATION AND PURIFICATION; PRECLINICAL STUDY; PREVENTION AND CONTROL; PROCEDURES; THEORETICAL MODEL; TRANSMISSION;

ANIMALS; ANTI-INFECTIVE AGENTS; DISEASE MODELS, ANIMAL; DISEASE TRANSMISSION, INFECTIOUS; DRUG EVALUATION, PRECLINICAL; HIV INFECTIONS; HUMANS; MODELS, THEORETICAL;

EID: 84939237859     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2015.05.001     Document Type: Note

References (15)

1. Abdool Karim Q., et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010, 329:1168-1174.
2. Parrish N.F., et al. Phenotypic properties of transmitted founder HIV-1. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:6626-6633.
3. Del Prete G.Q., et al. Selection of unadapted, pathogenic SHIVs encoding newly transmitted HIV-1 envelope proteins. Cell Host Microbe 2014, 16:412-418.
4. Munch J., et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 2007, 131:1059-1071.
5. Kim K.A., et al. Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI. Retrovirology 2010, 7:55.
6. Roan N.R., et al. Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection. Cell Host Microbe 2011, 10:541-550.
7. Zirafi O., et al. Semen enhances HIV infectivity and impairs the antiviral efficacy of microbicides. Sci. Transl. Med. 2014, 6:262ra157.
8. Fichorova R.N., et al. Novel vaginal microflora colonization model providing new insight into microbicide mechanism of action. MBio 2011, 2. e00168-11.
9. Lackman-Smith C., et al. Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides. Antimicrob. Agents Chemother. 2008, 52:1768-1781.
10. Doncel G.F., Clark M.R. Preclinical evaluation of anti-HIV microbicide products: New models and biomarkers. Antiviral Res. 2010, 88(Suppl. 1):S10-S18.
11. Denton P.W., Garcia J.V. Mucosal HIV-1 transmission and prevention strategies in BLT humanized mice. Trends Microbiol. 2012, 20:268-274.
12. + T cells mediated by DC-SIGN. J. Virol. 2007, 81:13723-13734.
13. Miller C.J., et al. Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J. Virol. 1994, 68:6391-6400.
14. Neildez O., et al. Variation in virological parameters and antibody responses in macaques after atraumatic vaginal exposure to a pathogenic primary isolate of SIVmac251. Res. Virol. 1998, 149:53-68.
15. Munch J., et al. Effect of semen and seminal amyloid on vaginal transmission of simian immunodeficiency virus. Retrovirology 2013, 10:148.